Push Admin

PH still in negotiations for COVID-19 vaccines, no clinical trial set yet

Article (news)

Kristine Sabillo, ABS-CBN News

<div class="embed-wrap"><figure data-feedback="fb:likes,fb:comments"><img src="http://sa.kapamilya.com/absnews/abscbnnews/media/2020/news/08/26/20200716-covid-19-vaccine-afp-3.jpg"/><figcaption>In this file photo, Dr. Nita Patel, Director of Antibody discovery and Vaccine development, lifts a vial with a potential COVID-19 vaccine at Novavax labs in Gaithersburg, Maryland on March 20, 2020, one of the labs developing a vaccine for the new coronavirus. Andrew Caballero-Reynolds, AFP</figcaption></figure></div>MANILA — The Philippines has not yet approved any clinical trials for COVID-19 vaccines, the country&#x27;s health department said Wednesday.“As of this week, wala pa tayong naaprubahan na clinical trial for any vaccine for COVID-19 dito sa ating country,” Health Undersecretary Maria Rosario Vergeire said during a virtual briefing.(As of this week we have not yet approved any clinical trial for any COVID-19 vaccine here in the country.)She said the negotiations with vaccine manufacturers and countries “committed to help the Philippines” are still ongoing.This includes the Sputnik vaccine from Russia. Vergeire said the results of its Phase II trials are sill being studied by the government’s expert panel.The Philippines&#x27; neighbor, Indonesia, has signed a deal with China’s Sinovac Biotech to locally produce at least 40 million doses of the vaccine it is developing. The so-called CoronaVac is undergoing Phase III Clinical Trials in Indonesia.<ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/overseas/08/11/20/indonesia-starts-human-trials-of-china-made-virus-vaccine">READ: Indonesia starts human trials of China-made virus vaccine</a></li></ul>“According sa President ng Indonesia, si President (Joko) Widodo, sabi nila mga mid-2021 pa sila matatapos at makakapag-release ng bakunang ito,” Vergeire said.(According to the President of Indonesia, President Widodo, they said they will finish and release the vaccine by mid-2021.)Sinovac is among the vaccines initially approved by the Inter-Agency Task Force on COVID-19 but its proposed clinical trials in the Philippines have not yet pushed through.Vergeire pointed out that unlike the other vaccines, Sinovac uses the whole inactivated virus in its vaccine.The Department of Science and Technology said last week that COVID-19 vaccines would probably be available to the Filipino public in the second quarter of 2021.<ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/news/08/19/20/covid-19-vaccine-likely-available-in-ph-en-masse-by-2nd-quarter-2021-dost">READ: COVID-19 vaccine likely available in PH &#x27;en masse&#x27; by 2nd quarter 2021- DOST</a></li></ul>The country has logged over 200,000 confirmed COVID-19 cases, as of Wednesday, of which, more than 65,000 are active. <ul class="op-related-articles">	<li><a href="https://news.abs-cbn.com/news/08/26/20/philippines-covid19-cases-coronavirus-infections-update-tally-august262020">COVID-19 cases in Philippines breach 200,000</a></li></ul>

The Philippines has not yet approved any clinical trials for COVID-19 vaccines, the country's health department said Wednesday.

The Philippines has not yet approved any clinical trials for COVID-19 vaccines, the country's health department said Wednesday.

PH still in negotiations for COVID-19 vaccines, no clinical trial set yet

News

Entertainment

Lifestyle

Sports

Metro.Style

More

Traffic

Manila

Horoscope

News

PH still in negotiations for COVID-19 vaccines, no clinical trial set yet

Kristine Sabillo,

ABS-CBN News

Published Aug 26, 2020 04:47 PM PHT

Read More:

COVID-19

coronavirus

COVID-19 vaccine

World Health Organization

Sinovac

Sputnik vaccine

Russia COVID-19 vaccine

ABS-CBN is the leading media and entertainment company in the Philippines, offering quality content across TV, radio, digital, and film. Committed to public service and promoting Filipino values, ABS-CBN continues to inspire and connect audiences worldwide.

Corporate

Investors

Governance

International Distribution

Corporate

Governance

Investors

International Distribution

NPC Seal of Registration

Privacy Policy

AI Policy

Terms of Service

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.

NPC Seal of Registration

Privacy Policy

Terms of Service

AI Policy

Advertise with Us

© 2025 ABS-CBN Corporation. All Rights Reserved.